Interactive tutorial on clinical trials

Interactive tutorial on clinical trials

U.S. government Web sites provide information about clinical studies, drug development, and other health care issues.

http://www.nlm.nih.gov/medlineplus/tutorials/clinicaltrials/htm/index.htm

Read more...

Jaundice (Kamala in Ayurveda Manjal Kaamalai in Siddha) Clinical Trials and conditions

Jaundice (Kamala in Ayurveda Manjal Kaamalai in Siddha) Clinical Trials and conditions

1  Human Kidney Histopathology in Obstructive Jaundice

Condition: Patients With Obstructive Jaundice

2 Breastfeeding Support Intervention in Jaundiced Infants

Conditions: Jaundice;   Breastfeeding

3  Immune Function in Patients With Obstructive Jaundice

Conditions: Obstructive Jaundice;   Disease as Reason for ERCP;   Immune Dysfunction;   Immune

4  Transcutaneous Bilirubinometers in the Community

Condition: Jaundice, Neonatal

5  Role of Endoscopic RFA in Prolonging the Patency of Metal Stents in Patients With Malignant Obstructive Jaundice

Conditions: Jaundice Extrahepatic Obstructive;   Disorder of Bile Duct Stent

6  Transcutaneous Bilirubinometry in Healthy Term and Near-Term Neonates

Condition: Hyperbilirubinemia

7  Transcutaneous Measurement of Jaundice in the Newborn

Conditions: Hyperbilirubinemia, Neonatal;   Jaundice, Neonatal

8  Treatment of Neonatal Jaundice With Filtered Sunlight Phototherapy: Safety and Efficacy in African Neonates

Condition: Jaundice, Neonatal

9 Randomised Trial Comparing Metal and Plastic Biliary Stents Stents for Palliating Malignant Jaundice

Condition: Biliary Obstruction

10  Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma

Conditions: Hepatocellular Carcinoma;   Obstructive Jaundice

11  Prediction of Jaundice in Term Infants

Conditions: Infant, Newborn;   Jaundice

12 Evaluation of Immune Function in Biliary Atresia Children With Prolonged Jaundice

Condition: Biliary Atresia

13  Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers

Conditions: Periampullary Cancers Causing Obstructive Jaundice;   Pancreas Head Cancer;   Bile Duct Cancer;   Carcinoma of Ampulla of Vater

14  Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)

Conditions: Biliary Tract Neoplasms;   Pancreatic Neoplasms;   Jaundice, Obstructive

               

15  Compassionate Use of Stannsoporfin in Addition to Phototherapy to Reduce the Need for Exchange Transfusions in Term and Near-Term Infants

Conditions: Neonatal Hyperbilirubinemia;   Neonatal Jaundice;   Jaundice;   Hyperbilirubinemia

16  Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis

Conditions: ABO Incompatibility;   Hemolytic Disease of Newborn;   Neonatal Jaundice;   Neonatal Hyperbilirubinemia

17 Effect of Timing of Umbilical Cord Clamping on Haematological and Clinical Outcomes of Infants

Conditions: Anemia;   Ferritin;   Complications;   Hemorrhage;   Jaundice

18  Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer

Conditions: Gallbladder Cancer;   Obstructive Jaundice

19  Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression

Conditions: Obstructive Jaundice;   Pancreatic Cancer

20  Stenting Malignant Jaundice for Quality of Life

Condition: Bile Duct Neoplasms Malignant

21  Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct

Condition: Jaundice

22 Compassionate Use of Stanate (TM) [Stannsoporfin]

Conditions: Neonatal Jaundice;   Hyperbilirubinemia

23  Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized Trial

Condition: Neonatal Jaundice

24  Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia

Conditions: Hyperbilirubinemia;   Jaundice

25  ComVi Stent Versus Uncovered Self-Expandable Metal Stent (SEMS) for Biliary SEMS Occlusion

Conditions: Biliary Tract Neoplasms;   Jaundice, Obstructive

Interventions: Device: ComVi stent;   Device: Uncovered SEMS

Outcome Measure: Time to stent occlusion

26  A Prospective, Randomized Study Evaluating the Effect of Biliary Stenting on EAU-FNA in Patients With Suspected Malignant Biliary Obstruction

Condition: Jaundice

27  Expression of BCRP in Icteric Patients

Condition: Icterus

28  Endoscopic Ultrasound Versus Endoscopic Retrograde Cholangiopancreatography (ERCP) Tissue Sampling for the Diagnosis of Suspected Pancreatico-Biliary Cancer

Conditions: Pancreaticobiliary Cancers;   Jaundice;   Bile Duct Obstruction

29 Acute Viral Hepatitis and Diabetes Mellitus

Conditions: Acute Viral Hepatitis;   Diabetes Mellitus

30  Outcome of Carbon Dioxide Versus Air Insufflations During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Condition: Obstructive Jaundice

31  Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

Conditions: Ampullary Cancer;   Duodenal Cancer;   Bile Duct Cancer;   Bile Duct Disorders;   Gallstones;   Obstructive Jaundice;   Pancreatic Disorders (Noncancerous);   Colorectal Cancer;   Esophageal Cancer;   Barrett's Esophagus;   Gastric Malignancies;   Pancreatic Cancer;   Pediatric Gastroenterology;   Cholangiocarcinoma;   Pancreatic Pseudocysts;   Acute and Chronic Pancreatitis;   Recurrent Pancreatitis;   Cholangitis;   Bile Leak;   Biliary Strictures;   Pancreatic Divisum;   Biliary and Pancreatic Stones;   Choledocholithiasis

32  Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight

33  Improving Health Outcomes for New Mothers and Babies

34  Effect of Benadryl Sedation During ERCP or EUS

Conditions: Gallbladder Disease;   Gallstones;   Pancreatitis;   Abdominal Pain;   Jaundice

35 Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year

36  Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer

Conditions: Pancreatic Neoplasms;   Biliary Tract Neoplasms;   Duodenal Neoplasms

37  RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction

Conditions: Biliary Tract Neoplasms;   Pancreatic Neoplasms;   Stents

38  Light-emitting Diodes (LED) Phototherapy for Hyperbilirubinemia of Term Newborn

Condition: Hyperbilirubinemia

39  Comparison of Biliary Stenting Alone vs. Stenting With Photodynamic Therapy During ERCP

Condition: Cholangiocarcinoma

40  Covered or Uncovered Bile Duct Stents

Condition: Bile Duct Neoplasms

41 A Trial Comparing the Uncovered to the Covered Wallstent in the Palliation of Malignant Bile Duct Strictures

Condition: Inoperable Tumors of the Bile Duct

42  The Effect of Hyperbilirubinemia on CV Disease, Neurocog Function and Renal Function

Condition: HIV

43  Atazanavir/Ritonavir and Zinc Pharmacokinetic Study

Condition: HIV Infection

44  Reverse Phototherapy With Super Light-emitting Diode(Super-LED) for Hyperbilirubinemia in Term and Late Preterm Infants

45  Safety and Pharmacology of Stanate

Condition: Hyperbilirubinemia

46  GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Conditions: Adenocarcinoma of the Pancreas;   Advanced Solid Tumors;   Cancer;   Cancer of Pancreas;   Cancer of the Pancreas;   Metastases;   Metastatic Cancer;   Metastatic Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Cancer;   Bone Metastases;   Endocrine Cancer;   Oncology;   Oncology Patients;   Solid Tumors;   Advanced Malignancy

47  Early Versus Delayed Cord Clamping at Term: Outcomes in Swedish Infants

Conditions: Iron Deficiency;   Neonatal Hyperbilirubinemia

48  RCT of Steroids Following Kasai Portoenterostomy for Biliary Atresia.

Condition: Biliary Atresia

49  Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi

Conditions: Cancer of Bile Duct;   Pancreatic Cancer

50 Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.

51  Covered Self-expandable Metal Stents for Palliation of Malignant Biliary Strictures: Evaluation of a New Type of Stent

Condition: Malignant Biliary Strictures

Intervention: Device: Endoscopic retrograde cholangiography (ERC) (ComVi biliary stent)

52  Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants

Condition: Prematurity

53  Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia

54  Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block.

Condition: Gallbladder Cancer

55 NPD Measurements in PSC Patients

Condition: Primary Sclerosing Cholangitis

56  Recompensation of Exacerbated Liver Insufficiency With Hyperbilirubinemia and/or Encephalopathy and/or Renal Failure

Condition: Liver Failure

57  Survival With Own Liver of Conventional Versus Laparoscopic Kasai for Biliary Atresia

Condition: Biliary Atresia

58  Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC)

Conditions: Liver Diseases;   Alagille Syndrome;   Alpha 1-Antitrypsin Deficiency

59 S-1 and Photodynamic Therapy in Cholangiocarcinoma

Condition: Cholangiocarcinoma

60  Biliary Atresia Research Consortium

Conditions: Biliary Atresia;   Cholestasis

61  Biospecimens for Identification of Diseases of the Pancreas.

Conditions: Pancreatic Cancer;   Chronic Pancreatitis;   Type II Diabetes;   Pancreatic Cysts;   Control

62  Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis

Condition: Primary Sclerosing Cholangitis

63 Umbilical Cord Clamping and Infant Iron Status

Condition: Iron-Deficiency Anemia

64  A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

65  Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

Condition: Toxoplasmosis

66  Managing Diabetes During Pregnancy in the Wireless Age

67 Endoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic Head

Condition: Pancreatic Cancer

68  A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen

Condition: Non-Hodgkin's Lymphoma

69  a Randomized Multicenter Trial Comparing Vacuum Assisted Delivery With the New Device "iCUP" Versus the Reference Cup.

70  Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease

71  Cholestatic Drug-induced Liver Injury

Condition: Hepatitis, Toxic

72 Glycemic Response to Momordica Charantia in Type 2 Diabetes

Condition: Type 2 Diabetes

73  WallFlex Biliary Fully Covered (FC) Benign Stricture Study

Condition: Biliary Stricture

74  Comparative Tolerability of Protease Inhibitors

Condition: HIV

75  Winged Perimeter Versus Traditional Plastic Biliary Stent for Malignant Bile Duct Obstruction

Condition: Malignant Tumor of Extrahepatic Bile Duct

76  Early Provision of Enteral Microlipid and Fish Oil to Infants With Enterostomy

Conditions: Short Bowel Syndrome;   Necrotizing Enterocolitis;   Perforation of Small Intestine

77  Sirolimus for Autoimmune Disease of Blood Cells

Conditions: Autoimmune Pancytopenia;   Autoimmune Lymphoproliferative Syndrome (ALPS);   Evans

78 Myo-Inositol Administration in Gestational Diabetes

Condition: Gestational Diabetes Mellitus

79  Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease

Conditions: Hyperbilirubinemia;   Erythroblastosis, Fetal

80  Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol

Conditions: Mild Traumatic Brain Injury;   Post-Traumatic Stress Disorder

81  Cohort of Hepatitis B Research of Amsterdam

Condition: Hepatitis B

82  Infant Severe Sepsis and Bacterial Meningitis in Malawi

Condition: Infant Bacterial Meningitis

83  Transcutaneous Bilirubinometry in Neonates

Condition: Neonatal Hyperbilirubinemia

84  Prediction of Neonatal Hyperbilirubinemia

Condition: Hyperbilirubinemia, Neonatal

85  Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver Failure

Conditions: Acute on Chronic Liver Failure;   Hepatitis B

86  Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational Diabetes

87  Allogenic Bone Marrow Stem Cell Transplantation in Liver Failure

Condition: Liver Failure

88  Allogenic Bone Marrow Stem Cells Transplantation in Patients With Liver Cirrhosis

Condition: Liver Cirrhosis

89  Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis

Conditions: Liver Cirrhosis;   Fibrosis;   Liver Disease;   Digestive System Disease

90 Bone Mesenchymal Stem Cell (BMSC) Transplantation in Liver Cirrhosis Via Portal Vein

Condition: Liver Cirrhosis

91  Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children

Conditions: Acute Hepatitis A;   Hepatitis

92  Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients

Conditions: Liver Cirrhosis;   Radiology;   Mesenchymal Stem Cells;   Umbilical Cord

93  Allogeneic Bone Marrow Mesenchymal Stem Cells Transplantation in Patients With Liver Failure Caused by Hepatitis B Virus (HBV)

Condition: Liver Failure

Read more...

Current Clinical Trials on Vitiligo / Switra in Ayurveda / Venpadai in Siddha

Current Clinical Trials on Vitiligo (Switra in Ayurveda, Venpadai in Siddha)

1. HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home
2. Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
3. Vitiligo Skin Transplantation
4. Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents
5. Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)
6. Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo
7. Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)
8. Clinical Trial of Simvastatin to Treat Generalized Vitiligo
9. Botulinum Toxin Treatment for Localized Vitiligo
10. Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo
11. Punchgrafting Techniques for Vitiligo
12. Efficacy and Safety of ACH24 in the Treatment of Vitiligo
13. Treatment of Vitiligo With Low-energy Visible Light Laser
14. Narrowband UVB Treatment in Patients With Vitiligo
15. Topical Bimatoprost Solution 0.03%in Stable Vitiligo
16. Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo
17. Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment
18. Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo
19. Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
20. Questionnaire and Laboratory Data on Vitiligo Vulgaris
21. Emervel Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds
22. Safety Study of Cosmetic Tissue Augmentation in People of Color
23. Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma
24. Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
25. A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.
26. Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma
27. Post Market Safety Study and Effectiveness With Evolence in Subjects With Skin Color Types IV-VI

Read more...

100 Current clinical trial details on rheumatoid arthritis

100 Current clinical trial details on rheumatoid arthritis
Click on title to view details.

1. A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece
2. A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With Methotrexate
3. A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
4. A Pilot Study of Potassium Supplementation for Adult Patients With Rheumatoid Arthritis
5. A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis
6. A Study Comparing CRx-102 Plus Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in Rheumatoid Arthritis
7. A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis
8. A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis
9. A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
10. A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis
11. A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis
12. A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
13. A Study of the Safety of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
14. A Study on the Prevalence of the Anti-MCV Anti-body in an Irish Rheumatoid Arthritis (RA) Population and the Impact of Biomarker Status on the Management of Irish Patients With Early RA
15. A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood
16. A Trial to Evaluate the Safety and Tolerability of MT203 in Patients With Mild to Moderate Rheumatoid Arthritis
17. Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
18. Assessment of Body Image in Patients With Rheumatoid Arthritis
19. Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab
20. Atherosclerosis in Rheumatoid Arthritis
21. Clinically Important Changes in Rheumatoid Arthritis
22. Cognitive Behavioral Therapy Treatments for Adults With Rheumatoid Arthritis (The SARA Study)
23. Coping Skills Training for Early Rheumatoid Arthritis
24. Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)
25. Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis
26. Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis
27. Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)
28.  Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.
29. Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice
30. Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drug (DMARD)-Naïve Adults With Early Active Rheumatoid Arthritis
31. Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drug (DMARD)-Naïve Adults With Early Active Rheumatoid Arthritis
32. Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis
33. Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients
34. Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis
35. Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects
36. Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
37. Genetics of Rheumatoid Arthritis
38. Health Outcomes in Rheumatoid Arthritis
39. Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?
40. Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid Arthritis
41. Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis
42. Inflammation and Insulin Resistance in Rheumatoid Arthritis
43. Infliximab for the Treatment of Early Rheumatoid Arthritis
44. Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
45. Interest of a Standardized Monitoring of Rheumatoid Arthritis: The COMEDRA Trial
46. Iyengar Yoga for Young People With Rheumatoid Arthritis
47. Low Density Lipoprotein Cholesterol (CLDL) as a Cardiovascular Disease Risk Factor in Rheumatoid Arthritis
48. Lung Disease Associated With Rheumatoid Arthritis
49. Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)
50. Meditation-Based Stress Reduction in Rheumatoid Arthritis
51. Moderate Rheumatoid Arthritis (RA) With Enbrel
52. Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs
53. Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis
54. Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept
55. Orally Active, Small Molecule Inhibitor of MEK1 and MEK2 in Patients With Active Rheumatoid Arthritis
56. Patient Rheumatoid Arthritis Social Support Study
57. Phase II Study Evaluating the Safety and Efficacy of GSK315234 in Patients With Rheumatoid Arthritis
58. Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls
59. Positron Emission Tomography and Magnetic Resonance Imaging to Evaluate Synovial Blood Flow in Rheumatoid Arthritis Patients
60. PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease
61. Relaxation Response Training for the Treatment of Rheumatoid Arthritis
62. Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy
63. Rheumatoid Arthritis Disease Activity Monitor
64. Rheumatoid Arthritis DMARD Intervention and UtilizationStudy
65. Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy
66. Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
67. Rosuvastatin in Rheumatoid Arthritis (RORA)
68. Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis
69.  Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis
70.  Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)
71. Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis
72. Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis
73. Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
74. Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate
75. Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)
76. Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)
77. Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis
78. Standard Disease Activity Parameters and Step Activity in Patients With Rheumatoid Arthritis Receiving Etanercept
79. Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
80. Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy
81. Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg
82. Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
83. Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis
84. Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
85. Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders
86. Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis
87. Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis
88. Targeting Synovitis in Early Rheumatoid Arthritis
89. The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment (CARAT)
90. The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission. Preliminary Study
91. The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept
92. The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis
93. Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey
94. TIV and High Dose TIV in Subjects With Rheumatoid Arthritis
95. Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine
96. Treatment of Hypovitaminosis D in Rheumatoid Arthritis
97. Treatment of Vitamin D Deficiency in Patients With Rheumatoid Arthritis
98. Ultrasonography as a Biomarker in Early Rheumatoid Arthritis
99. Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis
100. Zostavax in Rheumatoid Arthritis

Read more...